/DO NOT DISTRIBUTE TO U.S. NEWS WIRE AGENCIES OR PUBLISH, DISTRIBUTE OR DISSEMINATE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, TO THE UNITED STATES (USA)/
TORONTO, Aug. 2, 2018 /CNW/ - LIVEWELL CANADA INC. (TSXV: LVWL) ("LiveWell Canada" or "the Company") is pleased to announce that David Rendimonti, President, will present at the upcoming Benzinga Cannabis Capital Conference on Friday, August 17, at Arcadian, 401 Bay Street, Toronto, Ontario.
Mr. Rendimonti's presentation will offer this premier gathering of cannabis investors and entrepreneurs in North America an opportunity to hear about how LiveWell Canada is innovating the global cannabis and hemp markets by focusing, through technology and data, on prescription and consumer health products. LiveWell Canada's management will also be available for one-on-one meetings at the conference.
About LiveWell Canada
LiveWell Canada Inc. (TSX-V:LVWL) is an innovative Canadian company planning to become a leader in a new approach to health and wellness by conducting advanced studies on cannabidiol (CBD) and other cannabinoids in its world-class Research and Innovation Centre located in Litchfield, Québec. The company's mission also includes developing and distributing prescription and consumer health products. With more than 1.5 million square feet of greenhouses under construction located in Ontario and Québec, the company is supported by renowned academic and business partners such as Canopy Growth (TSX:WEED, NYSE:CGC) and Canopy Rivers. For more information, visit livewellcorp.com
Cautionary Note Regarding Forward-Looking Statements
This release includes forward-looking statements about the Company and its business. Often, but not always, forward-looking statements can be identified by the use of words such as "plan", "continue", "expect", "schedule", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements (including negative variations) that certain events or conditions "may" or "will" occur. Such statements are based on the current expectations of management. The forward-looking events and circumstances discussed in this release may not occur by certain specified dates or at all and could differ materially as a result of unknown and known risk factors and uncertainties affecting the Company, including risks regarding the cannabis and hemp industry, economic factors, the equity markets and risks associated with growth and competition. The Company cautions that this foregoing list of material factors is not exhaustive, and readers are encouraged to read all Risk Factors disclosed in the Company's Filing Statement dated May 29, 2018.
The forward-looking information contained in this press release represents expectations of the Company as of the date of this press release and accordingly, is subject to change after such date. Readers should not place undue importance on forward-looking information and should not rely upon this information as of any other date. While the Company may elect to, it does not undertake to update this information at any particular time except as required in accordance with applicable securities laws.
For more information, visit livewellcorp.com
SOURCE LiveWell Canada Inc.
For further information: Media, Sonya Lord, 866 308-1518, email@example.com; Léa Manuel, 514 569-7282, firstname.lastname@example.org; Investors, Nicole Marchand, 416 428-3533, email@example.com